Abnova (Taiwan) Corporation (TPE:4133)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
23.50
+0.15 (0.64%)
Mar 10, 2026, 1:30 PM CST
-20.61%
Market Cap 1.43B
Revenue (ttm) 351.30M
Net Income (ttm) -1.14M
Shares Out 60.55M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend 0.90 (3.85%)
Ex-Dividend Date Jun 16, 2025
Volume 78,579
Average Volume 380,743
Open 23.35
Previous Close 23.35
Day's Range 23.35 - 23.75
52-Week Range 21.70 - 35.10
Beta 0.47
RSI 38.65
Earnings Date Feb 26, 2026

About Abnova (Taiwan)

Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies. The company’s products portfolio includes SARS-CoV/CoV-2 DNA, RNA, proteins/peptides, lysates/slides, Ab pairs/kits, Ab arrays, polyclinic antibody, beads/dyes, in situ hybridization products, systems, and automations. It also offers MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and circulating rare cell antibodies. In addition, the company provides integrated solutions and services, including gene synthesis an... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 4133
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.